115 articles, page 1 of 10
Newest first
The two leading GLP-1 weight loss medications compared at the molecule level. Mechanism, clinical-trial efficacy, side effects, cost, cardiovascular outcomes, and the framework Harbor's clinical team uses to choose between them.
By Harbor Health Team
Zepbound is brand-name tirzepatide for weight loss. Compounded tirzepatide is the same molecule prepared differently. The choice in 2026 comes down to cost, insurance coverage, and tolerance for the trade-offs of each path. Written by Harbor's medical team.
By Harbor Health Team
Two FDA-approved weight loss injections from competing manufacturers, compared on every metric that matters in 2026. Mechanism, trial-grade efficacy, side effects, real cost, and how to choose, by Harbor's medical team.
By Harbor Health Team
Mounjaro and compounded tirzepatide contain the exact same active ingredient. The differences are FDA label, manufacturer, cost, and regulatory framework. Here's the honest breakdown from Harbor's medical team.
By Harbor Health Team
A side-by-side clinical comparison of tirzepatide and Ozempic for weight loss. Mechanism, trial-grade efficacy, side effects, real cost in 2026, and exactly how to switch, by Harbor's medical team.
By Harbor Health Team
A skipped or delayed weekly injection is one of the most common stressors in modern weight loss treatment.
By Harbor Health Team
Phentermine has been on the U.S. market longer than any other prescription medication still used for weight loss.
By Harbor Health Team
Orlistat is one of the few FDA-approved weight-loss medications you can purchase over the counter.
By Harbor Health Team
GLP-1 medications produce significant weight loss through appetite suppression and caloric reduction.
By Harbor Health Team
The number of GLP-1 medications available for weight loss has expanded significantly in recent years, and the decision of which one to use is no longer straightforward.
By Harbor Health Team
Most people who lose weight gain it back. That statement is supported by decades of clinical research showing that 80% to 90% of individuals who achieve meaningful weight loss eventually return to their starting weight or close to it.
By Harbor Health Team
Starting a GLP-1 medication for weight loss is a clinical decision, and the lab work surrounding that decision is just as important as the prescription itself.
By Harbor Health Team
